| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |